Home LiteratureArticle Details
PMID: 14507994 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.

Linares LK, Hengstermann A, Ciechanover A, Müller S, Scheffner M

Abstract

The RING finger proteins HdmX and Hdm2 share significant structural and functional similarity. Hdm2 is a member of the RING finger family of ubiquitin-protein ligases E3 and targets the tumor suppressor protein p53 for degradation. Although HdmX also binds to p53, HdmX does not induce p53 degradation. Moreover, HdmX has been reported to interfere with p53 degradation in overexpression experiments. To obtain insight into the mechanism by which HdmX interferes with p53 degradation, we studied the effect of HdmX on the E3 activity of Hdm2 in vitro. Surprisingly, this revealed that HdmX stimulates Hdm2-mediated ubiquitination of p53 and that HdmX facilitates ubiquitination of Hdm2 and vice versa. In addition, down-regulation of HdmX expression within cells results in the accumulation of both p53 and Hdm2. Because HdmX alone does not have appreciable E3 activity, these data indicate that HdmX acts as a stimulator, rather than as an inhibitor, of the E3 activity of Hdm2 and that, at least under certain conditions, HdmX is actively involved in the degradation of both p53 and Hdm2.

MeSH Terms
Amino Acid Sequence Base Sequence Cell Line Humans In Vitro Techniques Molecular Sequence Data Nuclear Proteins Proto-Oncogene Proteins/genetics,metabolism Proto-Oncogene Proteins c-mdm2 RNA, Small Interfering/genetics Recombinant Fusion Proteins/genetics,metabolism Transfection Tumor Suppressor Protein p53/chemistry,metabolism Ubiquitin/metabolism Ubiquitin-Protein Ligases/metabolism
Chemicals
Nuclear Proteins Proto-Oncogene Proteins RNA, Small Interfering Recombinant Fusion Proteins Tumor Suppressor Protein p53 Ubiquitin MDM2 protein, human Proto-Oncogene Proteins c-mdm2 Ubiquitin-Protein Ligases
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Linares Laëtitia K
Center for Biochemistry, Medical Faculty, and Center for Molecular Medicine, University of Cologne, Joseph-Stelzmann-Strasse 52, 50931 Cologne, Germany.
Hengstermann Arnd
Ciechanover Aaron
Müller Stefan
Scheffner Martin
References (38)
38 references, click to expand
  1. MDM2 interacts with MDMX through their RING finger domains.
    FEBS Lett. 1999 Mar 19;447(1):5-9 PMID: 10218570
  2. Characterization of sequence elements involved in p53 stability regulation reveals cell type dependence for p53 degradation.
    Oncogene. 1998 Dec 3;17(22):2933-41 PMID: 9879999
  3. Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein.
    J Biol Chem. 1999 Dec 31;274(53):38189-96 PMID: 10608892
  4. Recognition of the polyubiquitin proteolytic signal.
    EMBO J. 2000 Jan 4;19(1):94-102 PMID: 10619848
  5. MdmX protects p53 from Mdm2-mediated degradation.
    Mol Cell Biol. 2000 Feb;20(3):1001-7 PMID: 10629057
  6. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.
    J Biol Chem. 2000 Mar 24;275(12):8945-51 PMID: 10722742
  7. Activity of MDM2, a ubiquitin ligase, toward p53 or itself is dependent on the RING finger domain of the ligase.
    Oncogene. 2000 Mar 9;19(11):1473-6 PMID: 10723139
  8. Cell cycle-regulated modification of the ribosome by a variant multiubiquitin chain.
    Cell. 2000 Jul 7;102(1):67-76 PMID: 10929714
  9. Hdmx stabilizes Mdm2 and p53.
    J Biol Chem. 2000 Sep 8;275(36):28039-44 PMID: 10827196
  10. Ubiquitin in chains.
    Trends Biochem Sci. 2000 Nov;25(11):544-8 PMID: 11084366
  11. Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells.
    Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1218-23 PMID: 11158620
  12. Themes and variations on ubiquitylation.
    Nat Rev Mol Cell Biol. 2001 Mar;2(3):169-78 PMID: 11265246
  13. Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53.
    Cancer Res. 2001 Mar 1;61(5):1839-42 PMID: 11280734
  14. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.
    J Biol Chem. 2001 May 4;276(18):14537-40 PMID: 11278247
  15. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.
    Nature. 2001 May 24;411(6836):494-8 PMID: 11373684
  16. TAK1 is a ubiquitin-dependent kinase of MKK and IKK.
    Nature. 2001 Jul 19;412(6844):346-51 PMID: 11460167
  17. Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization.
    J Biol Chem. 2001 Aug 17;276(33):31357-67 PMID: 11397792
  18. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53.
    Nat Genet. 2001 Sep;29(1):92-5 PMID: 11528400
  19. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.
    Nat Struct Biol. 2001 Oct;8(10):833-7 PMID: 11573085
  20. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms.
    EMBO Rep. 2001 Nov;2(11):1029-34 PMID: 11606419
  21. Mechanisms underlying ubiquitination.
    Annu Rev Biochem. 2001;70:503-33 PMID: 11395416
  22. The p53 and Mdm2 families in cancer.
    Curr Opin Genet Dev. 2002 Feb;12(1):53-9 PMID: 11790555
  23. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.
    Curr Opin Genet Dev. 2002 Feb;12(1):86-91 PMID: 11790560
  24. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.
    Physiol Rev. 2002 Apr;82(2):373-428 PMID: 11917093
  25. p53-Mdm2--the affair that never ends.
    Carcinogenesis. 2002 Apr;23(4):541-7 PMID: 11960904
  26. Mutual dependence of MDM2 and MDMX in their functional inactivation of p53.
    J Biol Chem. 2002 May 31;277(22):19251-4 PMID: 11953423
  27. Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase.
    J Biol Chem. 2002 Jun 14;277(24):22085-92 PMID: 11927591
  28. Live or let die: the cell's response to p53.
    Nat Rev Cancer. 2002 Aug;2(8):594-604 PMID: 12154352
  29. MdmX is a RING finger ubiquitin ligase capable of synergistically enhancing Mdm2 ubiquitination.
    J Biol Chem. 2002 Dec 20;277(51):49668-75 PMID: 12393902
  30. Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein.
    J Biol Chem. 2003 Feb 14;278(7):5255-63 PMID: 12431996
  31. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53.
    Nature. 1995 Nov 9;378(6553):203-6 PMID: 7477326
  32. Cloning of human ubiquitin-conjugating enzymes UbcH6 and UbcH7 (E2-F1) and characterization of their interaction with E6-AP and RSP5.
    J Biol Chem. 1996 Feb 2;271(5):2795-800 PMID: 8576257
  33. Cell type-specific inhibition of p53-mediated apoptosis by mdm2.
    EMBO J. 1996 Apr 1;15(7):1596-606 PMID: 8612583
  34. MDMX: a novel p53-binding protein with some functional properties of MDM2.
    EMBO J. 1996 Oct 1;15(19):5349-57 PMID: 8895579
  35. Mdm2 promotes the rapid degradation of p53.
    Nature. 1997 May 15;387(6630):296-9 PMID: 9153395
  36. Regulation of p53 stability by Mdm2.
    Nature. 1997 May 15;387(6630):299-303 PMID: 9153396
  37. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.
    FEBS Lett. 1997 Dec 22;420(1):25-7 PMID: 9450543
  38. Activation of the cell death program by nitric oxide involves inhibition of the proteasome.
    J Biol Chem. 1999 Jul 9;274(28):19581-6 PMID: 10391892
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2003-10-14
Epub
2003-00-24
Pages
12009-14
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC218704
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]